In a financial world where pundits continue writing their articles, blogs and analysis about an equity correction or a bond market crunch, would-be investors could be forgiven for keeping their cash in non-yielding bank accounts and accepting the eroding effects of inflation until a great opportunity presents itself.
The same pundits, however, are unlikely to be trumpeting the opportunity at the moment it arrives. In the meantime, there are returns to be had. The developed world has been through decades of underinvestment...
BB Biotech's Head of Investment, Daniel Koller, explains why the sector's fundamentals are all lined up to the upside.
Classes A and D remain unavailable
Has been sponsor since 2010
Hires RBC's Martin Heale
Bringing over two funds